4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-21-002830
CEO sold 3,484 shares at $53.34 ($185,837)
- CEO acquired 9,527 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2021-01-06 | Option exercise | +9,527 | 27,966 | D | ||
| DAVIS STEPHEN CEO | 2021-01-06 | Sale | −3,484 | $53.34 | $185,837 | 24,482 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2021-01-06 | Option exercise · Restricted Stock Units | −9,527 | 28,583 | D | ||
| Open-market sales · 3,484 sh · avg $53.34 · $185,837 | |||||||
Loading xslF345X03/doc4.xml…